 Minh Luu
Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 18 | 2018 | 193 | 4.720 |
Why?
| | Herniorrhaphy | 7 | 2016 | 36 | 3.260 |
Why?
| | Postoperative Complications | 16 | 2018 | 1117 | 2.770 |
Why?
| | Cholecystectomy, Laparoscopic | 5 | 2018 | 40 | 2.180 |
Why?
| | Quality Improvement | 4 | 2014 | 173 | 1.790 |
Why?
| | Colectomy | 4 | 2016 | 32 | 1.720 |
Why?
| | General Surgery | 7 | 2015 | 62 | 1.570 |
Why?
| | Hernia, Ventral | 3 | 2016 | 23 | 1.570 |
Why?
| | Surgical Mesh | 3 | 2014 | 30 | 1.460 |
Why?
| | Hernia, Inguinal | 3 | 2016 | 23 | 1.230 |
Why?
| | Hernia, Hiatal | 4 | 2014 | 15 | 1.230 |
Why?
| | Gastrectomy | 2 | 2016 | 27 | 1.140 |
Why?
| | Carcinoma | 2 | 2016 | 77 | 1.110 |
Why?
| | Stomach Neoplasms | 2 | 2016 | 41 | 1.100 |
Why?
| | Smoking | 2 | 2016 | 206 | 1.070 |
Why?
| | Middle Aged | 29 | 2018 | 11216 | 1.010 |
Why?
| | Treatment Outcome | 20 | 2016 | 4035 | 0.990 |
Why?
| | Male | 37 | 2018 | 17724 | 0.970 |
Why?
| | Female | 37 | 2018 | 18420 | 0.950 |
Why?
| | Adult | 25 | 2018 | 9846 | 0.890 |
Why?
| | Colonic Neoplasms | 3 | 2016 | 81 | 0.800 |
Why?
| | Educational Measurement | 3 | 2015 | 69 | 0.790 |
Why?
| | Humans | 42 | 2018 | 32982 | 0.790 |
Why?
| | Internship and Residency | 4 | 2015 | 209 | 0.750 |
Why?
| | Retrospective Studies | 20 | 2018 | 3834 | 0.740 |
Why?
| | Databases, Factual | 6 | 2016 | 393 | 0.720 |
Why?
| | Pneumonia | 2 | 2016 | 75 | 0.710 |
Why?
| | Fundoplication | 3 | 2013 | 24 | 0.640 |
Why?
| | Cholecystectomy | 2 | 2018 | 19 | 0.640 |
Why?
| | Logistic Models | 5 | 2016 | 474 | 0.630 |
Why?
| | Splenic Neoplasms | 1 | 2016 | 2 | 0.600 |
Why?
| | Splenectomy | 1 | 2016 | 7 | 0.600 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2016 | 2 | 0.600 |
Why?
| | Duodenostomy | 1 | 2016 | 2 | 0.600 |
Why?
| | Jejunostomy | 1 | 2016 | 9 | 0.590 |
Why?
| | Cadherins | 1 | 2016 | 39 | 0.590 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2016 | 9 | 0.580 |
Why?
| | Enterostomy | 1 | 2016 | 6 | 0.580 |
Why?
| | Neoplasms, Second Primary | 1 | 2016 | 40 | 0.570 |
Why?
| | Aged | 17 | 2018 | 10540 | 0.570 |
Why?
| | Precancerous Conditions | 1 | 2015 | 27 | 0.570 |
Why?
| | Barrett Esophagus | 1 | 2015 | 18 | 0.570 |
Why?
| | End Stage Liver Disease | 1 | 2015 | 18 | 0.550 |
Why?
| | Certification | 1 | 2015 | 61 | 0.540 |
Why?
| | Gastroscopy | 1 | 2015 | 10 | 0.540 |
Why?
| | Gallbladder Neoplasms | 1 | 2015 | 7 | 0.540 |
Why?
| | Gastrostomy | 1 | 2015 | 12 | 0.540 |
Why?
| | Appendectomy | 1 | 2014 | 16 | 0.530 |
Why?
| | Appendicitis | 1 | 2014 | 18 | 0.530 |
Why?
| | Ovarian Neoplasms | 1 | 2016 | 80 | 0.530 |
Why?
| | Colon, Sigmoid | 1 | 2014 | 18 | 0.510 |
Why?
| | Scrotum | 1 | 2014 | 11 | 0.510 |
Why?
| | Survival Rate | 5 | 2015 | 443 | 0.510 |
Why?
| | Patient Safety | 1 | 2015 | 55 | 0.510 |
Why?
| | Credentialing | 1 | 2014 | 9 | 0.500 |
Why?
| | Biliary Dyskinesia | 1 | 2013 | 4 | 0.500 |
Why?
| | Gallstones | 1 | 2014 | 8 | 0.500 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2015 | 78 | 0.500 |
Why?
| | Mutation | 1 | 2016 | 464 | 0.490 |
Why?
| | Intestine, Small | 1 | 2014 | 37 | 0.490 |
Why?
| | Gastroplasty | 4 | 2014 | 28 | 0.480 |
Why?
| | Elective Surgical Procedures | 1 | 2014 | 56 | 0.480 |
Why?
| | Gallbladder Diseases | 1 | 2013 | 6 | 0.480 |
Why?
| | Head and Neck Neoplasms | 1 | 2015 | 141 | 0.480 |
Why?
| | Follow-Up Studies | 7 | 2015 | 2051 | 0.470 |
Why?
| | Abdominal Wall | 1 | 2013 | 4 | 0.470 |
Why?
| | United States | 8 | 2016 | 2632 | 0.470 |
Why?
| | Education, Medical, Graduate | 1 | 2013 | 93 | 0.440 |
Why?
| | Clinical Competence | 3 | 2015 | 284 | 0.440 |
Why?
| | Patient Satisfaction | 2 | 2013 | 325 | 0.430 |
Why?
| | Sepsis | 1 | 2014 | 160 | 0.430 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 20 | 0.430 |
Why?
| | Physicians | 1 | 2014 | 136 | 0.420 |
Why?
| | Operative Time | 5 | 2018 | 96 | 0.420 |
Why?
| | Esophagus | 1 | 2012 | 60 | 0.420 |
Why?
| | Risk Factors | 7 | 2016 | 2761 | 0.390 |
Why?
| | Heart Transplantation | 3 | 2015 | 51 | 0.380 |
Why?
| | Length of Stay | 4 | 2018 | 382 | 0.350 |
Why?
| | Obesity, Morbid | 3 | 2014 | 84 | 0.320 |
Why?
| | Image-Guided Biopsy | 2 | 2018 | 33 | 0.290 |
Why?
| | Clinical Clerkship | 3 | 2015 | 29 | 0.290 |
Why?
| | Graft Rejection | 3 | 2015 | 87 | 0.280 |
Why?
| | Surgical Wound Infection | 2 | 2016 | 106 | 0.250 |
Why?
| | Students, Medical | 2 | 2013 | 52 | 0.230 |
Why?
| | Comorbidity | 2 | 2016 | 563 | 0.230 |
Why?
| | Recurrence | 2 | 2014 | 398 | 0.230 |
Why?
| | Reoperation | 4 | 2016 | 970 | 0.220 |
Why?
| | Aged, 80 and over | 5 | 2018 | 5249 | 0.220 |
Why?
| | Predictive Value of Tests | 3 | 2015 | 626 | 0.170 |
Why?
| | Cholecystitis, Acute | 1 | 2018 | 8 | 0.170 |
Why?
| | Weight Loss | 3 | 2014 | 116 | 0.160 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 75 | 0.160 |
Why?
| | Survival Analysis | 2 | 2015 | 372 | 0.160 |
Why?
| | Lymph Nodes | 1 | 2018 | 84 | 0.160 |
Why?
| | Peripheral Vascular Diseases | 1 | 2016 | 15 | 0.150 |
Why?
| | Angina Pectoris | 1 | 2016 | 18 | 0.150 |
Why?
| | Antigens, CD | 1 | 2016 | 104 | 0.140 |
Why?
| | Anastomosis, Surgical | 1 | 2016 | 57 | 0.140 |
Why?
| | Age Factors | 2 | 2016 | 932 | 0.140 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 45 | 0.140 |
Why?
| | Cholangiography | 1 | 2015 | 12 | 0.140 |
Why?
| | Hernia, Umbilical | 1 | 2015 | 4 | 0.140 |
Why?
| | Confidence Intervals | 1 | 2015 | 102 | 0.140 |
Why?
| | Writing | 1 | 2015 | 23 | 0.140 |
Why?
| | Time Factors | 3 | 2015 | 1873 | 0.140 |
Why?
| | Multivariate Analysis | 1 | 2016 | 386 | 0.140 |
Why?
| | Intestines | 1 | 2016 | 115 | 0.140 |
Why?
| | Prospective Studies | 3 | 2018 | 2002 | 0.130 |
Why?
| | Cohort Studies | 3 | 2015 | 2077 | 0.130 |
Why?
| | Lymph Node Excision | 1 | 2015 | 36 | 0.130 |
Why?
| | Genetic Markers | 1 | 2015 | 64 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2015 | 30 | 0.130 |
Why?
| | Abdominal Neoplasms | 1 | 2014 | 12 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2016 | 160 | 0.130 |
Why?
| | Morbidity | 1 | 2014 | 72 | 0.130 |
Why?
| | Perioperative Care | 1 | 2015 | 74 | 0.130 |
Why?
| | Insurance, Health | 1 | 2014 | 27 | 0.130 |
Why?
| | Lymphoma | 1 | 2014 | 62 | 0.130 |
Why?
| | Radiography, Abdominal | 1 | 2014 | 7 | 0.130 |
Why?
| | Odds Ratio | 1 | 2015 | 321 | 0.130 |
Why?
| | Primary Graft Dysfunction | 1 | 2014 | 3 | 0.130 |
Why?
| | Sex Factors | 1 | 2016 | 548 | 0.130 |
Why?
| | Hemobilia | 1 | 2014 | 2 | 0.130 |
Why?
| | Respiratory Tract Fistula | 1 | 2014 | 2 | 0.130 |
Why?
| | Mirizzi Syndrome | 1 | 2014 | 2 | 0.130 |
Why?
| | Cutaneous Fistula | 1 | 2014 | 4 | 0.130 |
Why?
| | Ileus | 1 | 2014 | 4 | 0.130 |
Why?
| | Urinary Fistula | 1 | 2014 | 4 | 0.130 |
Why?
| | Biliary Fistula | 1 | 2014 | 6 | 0.130 |
Why?
| | Duodenal Diseases | 1 | 2014 | 7 | 0.130 |
Why?
| | Vascular Fistula | 1 | 2014 | 6 | 0.130 |
Why?
| | Intestinal Fistula | 1 | 2014 | 9 | 0.130 |
Why?
| | Hepatectomy | 1 | 2015 | 68 | 0.130 |
Why?
| | Colonic Diseases | 1 | 2014 | 17 | 0.120 |
Why?
| | Biopsy | 1 | 2015 | 277 | 0.120 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 182 | 0.120 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 189 | 0.120 |
Why?
| | Blood Transfusion | 1 | 2014 | 70 | 0.120 |
Why?
| | Graft Survival | 1 | 2014 | 110 | 0.120 |
Why?
| | Illinois | 1 | 2014 | 267 | 0.120 |
Why?
| | Specialties, Surgical | 1 | 2013 | 6 | 0.120 |
Why?
| | Animals, Laboratory | 1 | 2013 | 3 | 0.120 |
Why?
| | Hypertension | 1 | 2016 | 293 | 0.120 |
Why?
| | Myocardium | 1 | 2015 | 178 | 0.120 |
Why?
| | Prosthesis Implantation | 1 | 2013 | 40 | 0.120 |
Why?
| | Duodenal Neoplasms | 1 | 2013 | 9 | 0.120 |
Why?
| | Surgical Procedures, Operative | 1 | 2013 | 41 | 0.120 |
Why?
| | Hospital Mortality | 1 | 2015 | 197 | 0.120 |
Why?
| | Tissue Donors | 1 | 2014 | 85 | 0.120 |
Why?
| | Education, Medical, Undergraduate | 1 | 2013 | 37 | 0.120 |
Why?
| | Neoplasm Staging | 1 | 2015 | 457 | 0.120 |
Why?
| | Pancreaticoduodenectomy | 1 | 2013 | 31 | 0.120 |
Why?
| | Wound Healing | 1 | 2014 | 178 | 0.120 |
Why?
| | Education, Medical | 1 | 2013 | 48 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2014 | 319 | 0.120 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 40 | 0.120 |
Why?
| | Severity of Illness Index | 1 | 2018 | 1242 | 0.110 |
Why?
| | Heart Diseases | 1 | 2014 | 104 | 0.110 |
Why?
| | Radiography | 1 | 2014 | 717 | 0.110 |
Why?
| | Risk Assessment | 1 | 2015 | 814 | 0.110 |
Why?
| | Pancreatic Neoplasms | 1 | 2013 | 176 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2013 | 694 | 0.100 |
Why?
| | Pilot Projects | 3 | 2018 | 466 | 0.100 |
Why?
| | Gastroesophageal Reflux | 1 | 2009 | 38 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 899 | 0.090 |
Why?
| | Actinomycetales | 1 | 2004 | 1 | 0.070 |
Why?
| | Genes, Bacterial | 1 | 2004 | 9 | 0.060 |
Why?
| | Erythromycin | 1 | 2004 | 12 | 0.060 |
Why?
| | Young Adult | 2 | 2018 | 2287 | 0.040 |
Why?
| | Patient Admission | 1 | 2018 | 30 | 0.040 |
Why?
| | Blood Loss, Surgical | 1 | 2018 | 69 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2018 | 282 | 0.040 |
Why?
| | Job Application | 1 | 2015 | 8 | 0.030 |
Why?
| | Los Angeles | 1 | 2015 | 10 | 0.030 |
Why?
| | Algorithms | 1 | 2018 | 428 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 72 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2018 | 339 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 228 | 0.030 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 216 | 0.030 |
Why?
| | Ischemic Preconditioning, Myocardial | 1 | 2014 | 1 | 0.030 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2014 | 23 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 31 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 113 | 0.030 |
Why?
| | Preoperative Period | 1 | 2014 | 71 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2015 | 166 | 0.030 |
Why?
| | Cooperative Behavior | 1 | 2014 | 95 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 462 | 0.030 |
Why?
| | Program Evaluation | 1 | 2013 | 150 | 0.030 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 350 | 0.030 |
Why?
| | Postoperative Care | 1 | 2012 | 140 | 0.030 |
Why?
| | Anxiety | 1 | 2013 | 180 | 0.030 |
Why?
| | Prognosis | 1 | 2014 | 1011 | 0.020 |
Why?
| | Stress, Psychological | 1 | 2013 | 298 | 0.020 |
Why?
| | Body Mass Index | 1 | 2012 | 478 | 0.020 |
Why?
| | History, 18th Century | 1 | 2009 | 10 | 0.020 |
Why?
| | Treatment Failure | 1 | 2009 | 186 | 0.020 |
Why?
| | Glucosyltransferases | 1 | 2004 | 1 | 0.020 |
Why?
| | Saccharopolyspora | 1 | 2004 | 1 | 0.020 |
Why?
| | Transferases (Other Substituted Phosphate Groups) | 1 | 2004 | 1 | 0.020 |
Why?
| | Fatty Acid Synthases | 1 | 2004 | 1 | 0.020 |
Why?
| | Thiolester Hydrolases | 1 | 2004 | 3 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2004 | 4 | 0.020 |
Why?
| | Multigene Family | 1 | 2004 | 10 | 0.020 |
Why?
| | Sequence Homology | 1 | 2004 | 5 | 0.020 |
Why?
| | Gene Rearrangement | 1 | 2004 | 16 | 0.020 |
Why?
| | Cloning, Molecular | 1 | 2004 | 46 | 0.020 |
Why?
| | Gene Deletion | 1 | 2004 | 54 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2004 | 53 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 81 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2004 | 43 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 312 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2004 | 90 | 0.020 |
Why?
| | Animals | 1 | 2013 | 5368 | 0.010 |
Why?
|
|
Luu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|